N-(3-acyloxy-2-benzylpropyl)-N′-[4-(methylsulfonylamino)benzyl]thiourea analogues:: Novel potent and high affinity antagonists and partial antagonists of the vanilloid receptor

被引:113
作者
Lee, J [1 ]
Lee, J [1 ]
Kang, M
Shin, M
Kim, JM
Kang, SU
Lim, JO
Choi, HK
Suh, YG
Park, HG
Oh, U
Kim, HD
Park, YH
Ha, HJ
Kim, YH
Toth, A
Wang, Y
Tran, R
Pearce, LV
Lundberg, DJ
Blumberg, PM
机构
[1] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Kwanak Ku, Seoul 151742, South Korea
[2] Sookmyung Womens Univ, Coll Pharm, Seoul 140742, South Korea
[3] AmorePacific R&D Ctr, Yongin Si 449900, Kyounggi Do, South Korea
[4] Digital Biotech, Ansan 425839, Kyounggi Do, South Korea
[5] NCI, Ctr Canc Res, Cellular Carcinogenesis & Tumor Promot Lab, Bethesda, MD 20892 USA
关键词
D O I
10.1021/jm030089u
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Isosteric replacement of the phenolic hydroxyl group in potent vanilloid receptor (VR1) agonists with the alkylsulfonamido group provides a series of compounds which are effective antagonists to the action of the capsaicin on rat VR1 heterologously expressed in Chinese hamster ovary (CHO) cells. In particular, compound 61, N-[2-(3,4-dimethylbenzyl)-3-pivaloyloxypropyl]-N[3-fluoro-4-(methylsulfonylamino)benzyl] thiourea was a full antagonist against capsaicin, displayed a K-i value of 7.8 nM (compared to 520 nM for capsazepine and 4 nM for 5-iodoRTX), and showed excellent analgesic activity in mice. Structure-activity analysis of the influence of modifications in the A- and C-regions of 4-methylsulfonamide ligands on VR1 agonism/antagonism indicated that 3-fluoro substitution in the A-region and a 4-tert-butylbenzyl moiety in the C-region favored antagonism, whereas a 3-methoxy group in the A-region and 3-acyloxy-2-benzylpropyl moieties in the C-region favored agonism.
引用
收藏
页码:3116 / 3126
页数:11
相关论文
共 32 条
[11]   Intravesical resiniferatoxin for the treatment of hypersensitive disorder: A randomized placebo controlled study [J].
Lazzeri, M ;
Beneforti, P ;
Spinelli, M ;
Zanollo, A ;
Barbagli, G ;
Turini, D .
JOURNAL OF UROLOGY, 2000, 164 (03) :676-679
[12]   Phenolic modification as an approach to improve the pharmacology of the 3-acyloxy-2-benzylpropyl homovanillic amides and thioureas, a promising class of vanilloid receptor agonists and analgesics [J].
Lee, J ;
Lee, J ;
Kang, MS ;
Kim, KP ;
Chung, SJ ;
Blumberg, PM ;
Yi, JB ;
Park, YH .
BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (04) :1171-1179
[13]   N-(3-acyloxy-2-benzylpropyl)-N′-dihydroxytetrahydrobenzazepine and tetrahydroisoquinoline thiourea analogues as vanilloid receptor ligands [J].
Lee, J ;
Lee, J ;
Szabo, T ;
Gonzalez, AF ;
Welter, JD ;
Blumberg, PM .
BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (07) :1713-1720
[14]   N-(3-acyloxy-2-benzylpropyl)-N′-(4-hydroxy-3-methoxybenzyl) thiourea derivatives as potent vanilloid receptor agonists and analgesics [J].
Lee, J ;
Lee, J ;
Kim, J ;
Kim, SY ;
Chun, MW ;
Cho, HW ;
Hwang, SW ;
Oh, U ;
Park, YH ;
Marquez, VE ;
Beheshti, M ;
Szabo, T ;
Blumberg, PM .
BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (01) :19-32
[15]   Capsazepine, a vanilloid receptor antagonist, inhibits nicotinic acetylcholine receptors in rat trigeminal ganglia [J].
Liu, L ;
Simon, SA .
NEUROSCIENCE LETTERS, 1997, 228 (01) :29-32
[16]   Synthesis and in vitro evaluation of a novel iodinated resiniferatoxin derivative that is an agonist at the human vanilloid VR1 receptor [J].
McDonnell, ME ;
Zhang, SP ;
Dubin, AE ;
Dax, SL .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (08) :1189-1192
[17]  
Oh U, 1996, J NEUROSCI, V16, P1659
[18]   DA-5018.: Topical analgesic. [J].
Park, NS ;
Seong, CM ;
Jung, YS ;
Kim, WB ;
Kim, SH .
DRUGS OF THE FUTURE, 2000, 25 (11) :1131-1137
[19]   Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenyl acetate ester) iodo-resiniferatoxin [J].
Seabrook, GR ;
Sutton, KG ;
Jarolimek, W ;
Hollingworth, GJ ;
Teague, S ;
Webb, J ;
Clark, N ;
Boyce, S ;
Kerby, J ;
Ali, Z ;
Chou, M ;
Middleton, R ;
Kaczorowski, G ;
Jones, AB .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (03) :1052-1060
[20]   The cloned rat vanilloid receptor VR1 mediates both R-type binding and C-type calcium response in dorsal root ganglion neurons [J].
Szallasi, A ;
Blumberg, PM ;
Annicelli, LL ;
Krause, JE ;
Cortright, DN .
MOLECULAR PHARMACOLOGY, 1999, 56 (03) :581-587